http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
Current policies on early detection of prostate cancer create overdiagnosis and inequity with minimal benefit.
Vickers, A. ; O'Brien, F. ; Montorsi, F. ; Galvin, D. ; Bratt, O. ; Carlsson, S. ; Catto, J. W. ; Krilaviciute, A.DKFZ* ; Philbin, M. ; Albers, P. (Last author)DKFZ*
2023
BMJ Publ. Group
London
This record in other databases:

Please use a persistent id in citations: doi:10.1136/bmj-2022-071082
Note: #LA:C130#
Contributing Institute(s):
- Personalisierte Früherkennung des Prostatakarzinoms (C130)
Research Program(s):
- 313 - Krebsrisikofaktoren und Prävention (POF4-313) (POF4-313)
Appears in the scientific report
2023
Database coverage:
; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; Current Contents - Clinical Medicine ; Current Contents - Life Sciences ; Ebsco Academic Search ; Essential Science Indicators ; IF >= 90 ; JCR ; National-Konsortium ; PubMed Central ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection